"Levodopa phobia": a new iatrogenic cause of disability in Parkinson disease.
Kurlan
Roger
R
Department of Neurology, University of Rochester School of Medicine, Rochester, NY 14642, USA. Roger_Kurlan@urmc.rochester.edu
D000368:Aged; D000547:Amantadine / Q000627:therapeutic use; D052160:Benzothiazoles; D002396:Catechols / Q000627:therapeutic use; D015259:Dopamine Agents / Q000008:administration & dosage / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D004409:Dyskinesia, Drug-Induced / Q000503:physiopathology / Q000517:prevention & control*; D006801:Humans; D007049:Iatrogenic Disease / Q000517:prevention & control*; D007211:Indoles / Q000627:therapeutic use; D007980:Levodopa / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D009462:Neurology / Q000941:ethics / Q000592:standards; D009480:Neuropharmacology / Q000941:ethics / Q000592:standards; D020258:Neurotoxicity Syndromes / Q000503:physiopathology / Q000517:prevention & control*; D009570:Nitriles; D010300:Parkinson Disease / Q000188:drug therapy*; D000077487:Pramipexole; D012642:Selegiline / Q000627:therapeutic use; D013844:Thiazoles / Q000627:therapeutic use; D016896:Treatment Outcome
D052160:Benzothiazoles; D002396:Catechols; D015259:Dopamine Agents; D007211:Indoles; D009570:Nitriles; D013844:Thiazoles; C046649:ropinirole; D012642:Selegiline; D007980:Levodopa; C071192:entacapone; D000077487:Pramipexole; D000547:Amantadine